Skip to content

Public FDA record

Z-0993-2022: PrisMax System, Product Codes: a) 955558, b) 955627, c) 955701

Recall record Z-0993-2022 for Baxter Healthcare Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0993-2022
Company in FDA record
Baxter Healthcare Corporation
FDA record creation date
Apr 22, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

This correction is due to software anomalies occurring during use. If the operator initiates therapy by entering a value other than the default value for the patient Gain/Loss Limit or the Return Pressure Drop Limit (RDL) and uses the Same Patient function, the PrisMax System will return the patient Gain/Loss Limit or the RDL to the default value, rather than the non-default value entered at the initiation of treatment. The PrisMax System interface will display the original values once treatment is restarted but does not have an alert to inform the user of the change. The RDL value will be returned to the original value immediately upon selecting the Same Patient function. The Gain/Loss Limit value will be returned to the original value when the patient weight and/or hematocrit is changed during treatment.

Source facts

Action
The firm notified its consignees be letter on 03/15/2022. The following instructions were provided: "1. Operators may continue to safely use the PrisMax System. To ensure patient safety, there are two approaches to address the anomalies: Approach 1: Choose new patient at every filter set change. This will require re-input of all prescription settings and therapy will begin without prescription settings and treatment data from the previous filter set. Approach 2: Choose Same Patient when changing a filter set. Check and correct the Gain/Loss Limit or RDL prior to starting treatment. See Attachment A to change the Gain/Loss Limit See Attachment B to change the RDL The device should only be used by a trained operator per the instructions in the Operator s Manual. Please ensure that every operator of this device is made aware of this Urgent Medical Device Correction. 2. When the software upgrade becomes available, a local Baxter representative will contact your facility to determine the correction plan and schedule the upgrade for impacted devices. Your facility will be receiving this upgrade from Baxter at no charge. 3. Acknowledge the receipt of this notification by completing a reply form on the customer portal."
Initiated
2022-03-15
Root cause
Under Investigation by firm
Distribution
Worldwide distribution - US Nationwide and the countries of Mexico, Brazil, Jamaica, Trinidad and Tobago, Canada, Australia, Singapore, Hong Kong, Vietnam, New Zealand, Korea, Austria, Belgium, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Israel, Italy, Luxemburg, Netherlands, Norway, Poland, Portugal, Saudi Arabia, Spain, Sweden, Switzerland, Turkey, and United Kingdom.
Recall number
Z-0993-2022
Recall status
Open, Classified
CDRH record ID
192635
FDA record created
2022-04-22
Recall event number
89823

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗